MA27042A1 - FORMULATION PHARMACEUTIQUE AU GOûT MASQUÉ ET SON PROCÉDÉ DE PRÉPARATION. - Google Patents

FORMULATION PHARMACEUTIQUE AU GOûT MASQUÉ ET SON PROCÉDÉ DE PRÉPARATION.

Info

Publication number
MA27042A1
MA27042A1 MA27445A MA27445A MA27042A1 MA 27042 A1 MA27042 A1 MA 27042A1 MA 27445 A MA27445 A MA 27445A MA 27445 A MA27445 A MA 27445A MA 27042 A1 MA27042 A1 MA 27042A1
Authority
MA
Morocco
Prior art keywords
preparation
pharmaceutical formulation
masked taste
masked
taste
Prior art date
Application number
MA27445A
Other languages
English (en)
French (fr)
Inventor
Philippe Becourt
Josiane Chauvin
Detlev Schwabe
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MA27042A1 publication Critical patent/MA27042A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA27445A 2001-06-21 2003-12-16 FORMULATION PHARMACEUTIQUE AU GOûT MASQUÉ ET SON PROCÉDÉ DE PRÉPARATION. MA27042A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (1)

Publication Number Publication Date
MA27042A1 true MA27042A1 (fr) 2004-12-20

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27445A MA27042A1 (fr) 2001-06-21 2003-12-16 FORMULATION PHARMACEUTIQUE AU GOûT MASQUÉ ET SON PROCÉDÉ DE PRÉPARATION.

Country Status (41)

Country Link
US (2) US7138138B2 (OSRAM)
EP (1) EP1401397B1 (OSRAM)
JP (1) JP4880871B2 (OSRAM)
CN (1) CN1239149C (OSRAM)
AP (1) AP1595A (OSRAM)
AR (1) AR036096A1 (OSRAM)
AT (1) ATE290366T1 (OSRAM)
AU (1) AU2002329311B2 (OSRAM)
BG (1) BG66314B1 (OSRAM)
BR (1) BRPI0208998A2 (OSRAM)
CA (1) CA2452239C (OSRAM)
CO (1) CO5540278A2 (OSRAM)
CZ (1) CZ299947B6 (OSRAM)
DE (1) DE60203178T2 (OSRAM)
EA (1) EA006016B1 (OSRAM)
EC (1) ECSP034915A (OSRAM)
ES (1) ES2236574T3 (OSRAM)
FR (1) FR2826274B1 (OSRAM)
GT (2) GT200200115AA (OSRAM)
HR (1) HRP20031067B1 (OSRAM)
HU (1) HUP0400799A3 (OSRAM)
IL (2) IL159404A0 (OSRAM)
JO (1) JO2325B1 (OSRAM)
MA (1) MA27042A1 (OSRAM)
MX (1) MXPA03011756A (OSRAM)
MY (1) MY134340A (OSRAM)
NO (1) NO332258B1 (OSRAM)
NZ (1) NZ530042A (OSRAM)
OA (1) OA12635A (OSRAM)
PA (1) PA8548301A1 (OSRAM)
PE (1) PE20030201A1 (OSRAM)
PL (1) PL202090B1 (OSRAM)
PT (1) PT1401397E (OSRAM)
SK (1) SK285865B6 (OSRAM)
SV (1) SV2003001098A (OSRAM)
TN (1) TNSN03141A1 (OSRAM)
TW (1) TWI228049B (OSRAM)
UA (1) UA77960C2 (OSRAM)
UY (1) UY27341A1 (OSRAM)
WO (1) WO2003000225A2 (OSRAM)
ZA (1) ZA200309479B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
US20090011007A1 (en) * 2006-02-03 2009-01-08 Evonik Roehm Gmbh Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2379635T3 (en) 2008-12-16 2016-12-05 Carlsberg As Cellulosic polymer material
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
AU2015301154A1 (en) * 2014-08-05 2017-02-23 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US6153220A (en) * 1997-10-03 2000-11-28 Elan Corporation, Plc Taste-masked formulations
IN191239B (OSRAM) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
US6740642B2 (en) * 2000-08-22 2004-05-25 Basilea Parmaceutica Ag Macrolides with antibacterial activity

Also Published As

Publication number Publication date
OA12635A (fr) 2006-06-15
EA006016B1 (ru) 2005-08-25
CZ299947B6 (cs) 2009-01-07
EP1401397B1 (fr) 2005-03-09
EP1401397A2 (fr) 2004-03-31
PA8548301A1 (es) 2003-09-05
IL159404A (en) 2007-08-19
HUP0400799A3 (en) 2012-08-28
PL366803A1 (en) 2005-02-07
BRPI0208998A2 (pt) 2017-06-06
CZ20033441A3 (en) 2004-03-17
WO2003000225A3 (fr) 2003-03-13
GT200200115AA (es) 2005-01-12
IL159404A0 (en) 2004-06-01
TWI228049B (en) 2005-02-21
CA2452239C (fr) 2011-07-19
GT200200115A (es) 2003-02-27
ECSP034915A (es) 2004-02-26
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
DE60203178T2 (de) 2006-01-26
JP2004534810A (ja) 2004-11-18
HRP20031067B1 (en) 2011-10-31
UA77960C2 (en) 2007-02-15
US7138138B2 (en) 2006-11-21
PE20030201A1 (es) 2003-03-12
DE60203178D1 (de) 2005-04-14
PT1401397E (pt) 2005-05-31
MXPA03011756A (es) 2004-07-01
ES2236574T3 (es) 2005-07-16
HRP20031067A2 (en) 2004-04-30
JP4880871B2 (ja) 2012-02-22
JO2325B1 (en) 2006-06-28
TNSN03141A1 (fr) 2005-12-23
SK285865B6 (sk) 2007-10-04
HK1067558A1 (en) 2005-04-15
AP1595A (en) 2006-04-12
WO2003000225A2 (fr) 2003-01-03
ATE290366T1 (de) 2005-03-15
AP2003002927A0 (en) 2003-12-31
NO20035581D0 (no) 2003-12-15
FR2826274B1 (fr) 2003-09-26
CO5540278A2 (es) 2005-07-29
US20070014857A1 (en) 2007-01-18
US20040142029A1 (en) 2004-07-22
BG108458A (bg) 2005-02-28
MY134340A (en) 2007-12-31
SV2003001098A (es) 2003-03-18
CN1239149C (zh) 2006-02-01
SK15922003A3 (sk) 2004-05-04
FR2826274A1 (fr) 2002-12-27
AR036096A1 (es) 2004-08-11
BG66314B1 (bg) 2013-04-30
NZ530042A (en) 2005-09-30
CN1529585A (zh) 2004-09-15
NO332258B1 (no) 2012-08-13
EA200400061A1 (ru) 2004-06-24
UY27341A1 (es) 2003-01-31
AU2002329311B2 (en) 2007-02-01
CA2452239A1 (fr) 2003-01-03
HUP0400799A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
MA27042A1 (fr) FORMULATION PHARMACEUTIQUE AU GOûT MASQUÉ ET SON PROCÉDÉ DE PRÉPARATION.
EE200300370A (et) Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300369A (et) Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
LTPA2014005I1 (lt) Chinazolidino dariniai, minėtus junginius turintys vaistai, jų panaudojimas ir jų gavimo būdas
FR2824825B1 (fr) Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA27049A1 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
HUT77655A (hu) Trombózisellenes gyógyszerkészítmény és eljárás előállítására
EE200300237A (et) Difenüülasetidinooni derivaadid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300238A (et) Difenüülasetidinooni derivaadid, nende kasutamine, ravim ja selle valmistamismeetod
EE03904B1 (et) Graanul, farmatseutiline doseerimisvorm, graanulite valmistamismeetod ja ravimiga kaetud graanulid
FR2822827B1 (fr) Nouveaux derives de n-(arylsulfonyl) beta-aminoacides comportant un groupe aminomethyle substitue, leur procede de preparation et les compositions pharmaceutiques en contenant
EE200400028A (et) Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
FR2809730B1 (fr) Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
EE03663B1 (et) Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
FR2846656B1 (fr) Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
DK1178799T3 (da) Gastrobeskyttede mikrogranula, fremgangsmåde til opnåelse af samme og farmaceutiske præparater
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
FR2845388B1 (fr) Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
EP1476174A4 (en) PHARMACEUTICAL PREPARATION WITH PROPHYLACTIC EFFECTS ON LAMIVUDINE-RELATED REACTIONS AND PHARMACORESISTANCE, AND METHODS OF USING THE SAME
FR2825091B1 (fr) Nouveaux derives tricycliques de dihydro-quinnoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2822153B1 (fr) Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL369632A1 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique